Analyst Ratings for Lisata Therapeutics, Inc (LSTA)

LSTA Rating Summary

  |   Expand Research on LSTA
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: N/A
Rating Score: 3.3 / 10   Percentile Rank: 30%
Date Firm Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
5/15/2026 H.C. Wainwright Joseph Pantginis Downgrade Neutral
(Buy)		 N/A
(N/A)		 3.08
(3.48)		 12.99% Details
1/21/2026 Brookline Capital Markets Kemp Dolliver Downgrade Hold
(Buy)		 N/A
(N/A)		 2.16
(3.48)		 61.11% Details